Biosante Pharmaceuticals shares owned by Citigroup
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $11M | 144k | 76.90 |
| 2025-03-31 | $1.9M | 28k | 66.95 |
| 2024-12-31 | $2.0M | 35k | 55.28 |
| 2024-09-30 | $1.6M | 28k | 59.66 |
| 2024-06-30 | $1.0M | 16k | 63.68 |
| 2024-03-31 | $1.3M | 18k | 69.13 |
| 2023-12-31 | $788k | 14k | 55.14 |
| 2023-09-30 | $497k | 8.6k | 58.06 |
| 2023-03-31 | $250k | 6.3k | 39.72 |
| 2022-12-31 | $321k | 8.0k | 40.23 |
| 2022-09-30 | $223k | 6.9k | 32.16 |
| 2021-12-31 | $398k | 8.6k | 46.09 |
| 2021-03-31 | $53k | 1.5k | 36.25 |
| 2020-12-31 | $90k | 3.1k | 28.91 |
| 2020-09-30 | $73k | 2.6k | 28.13 |
| 2020-06-30 | $191k | 5.9k | 32.39 |
| 2020-03-31 | $281k | 6.8k | 41.01 |
| 2019-12-31 | $561k | 9.3k | 60.09 |
| 2019-09-30 | $6.3M | 86k | 72.85 |
| 2019-06-30 | $1.4M | 17k | 82.25 |
| 2019-03-31 | $232k | 3.3k | 70.22 |
| 2018-12-31 | $2.1M | 47k | 45.06 |
| 2018-09-30 | $2.7M | 49k | 56.54 |
| 2018-06-30 | $1.6M | 23k | 66.83 |
| 2018-03-31 | $2.4M | 41k | 58.24 |
| 2017-12-31 | $2.3M | 36k | 64.47 |
| 2017-09-30 | $1.7M | 33k | 52.47 |
| 2017-06-30 | $908k | 19k | 46.82 |
| 2017-03-31 | $1.5M | 31k | 49.51 |
| 2016-12-31 | $2.5M | 41k | 60.62 |
| 2016-09-30 | $726k | 11k | 66.40 |
| 2016-06-30 | $286k | 5.1k | 55.87 |
| 2015-12-31 | $0 | 427 | 0.00 |
| 2015-09-30 | $38k | 932 | 41.18 |
| 2015-06-30 | $45k | 741 | 60.00 |
| 2014-09-30 | $7.2k | 271 | 26.42 |